Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

Acne Infection

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

Phase II Reactions: Methylation Reactions

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Anaplastic large-cell lymphoma CD30(+) ALK(+)].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2015

Same author

[Clinical and microbiological characteristics of severe infections caused by group A streptococci].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2015

Same author

Hidradenitis suppurativa treated with combination of infliximab and dapsone.

Bratislavske lekarske listy·2012

Same author

[Superficial thrombophlebitis--diagnostics and treatment].

Vnitrni lekarstvi·2009

Same author

Dermatitis herpetiformis in siblings.

Bratislavske lekarske listy·2008

Same author

[Yeasts and fungi isolated at the mycology laboratory of the First Dermatovenerology Clinic of the Medical Faculty Hospital of Comenius University in Bratislava 1995-2000].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2003

Search research articles

Related Experiment Video

Updated: May 31, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Systemic therapy of psoriasis: methotrexate.

P Kozub¹, M Simaljakova

¹Department of Dermatology, Faculty of Medicine, University Hospital, Bratislava, Slovakia. peter.kozub@laposte.net

Bratislavske Lekarske Listy

|July 13, 2011

Summary

Methotrexate is a widely used treatment for psoriasis and psoriatic arthritis, offering immunosupressive and anti-inflammatory benefits. Understanding its mechanism, toxicity, and management is crucial for effective patient care.

Area of Science:

Immunology
Dermatology
Rheumatology

Background:

Methotrexate is a primary treatment for moderate to severe psoriasis and psoriatic arthritis globally.
Its efficacy stems from immunosupressive and anti-inflammatory actions.

Purpose of the Study:

To elucidate the mechanism of action of methotrexate in treating psoriasis and psoriatic arthritis.
To detail the potential toxicities associated with methotrexate therapy.
To provide strategies for managing methotrexate toxicity.

Main Methods:

Literature review and synthesis of existing research on methotrexate.
Analysis of clinical data regarding efficacy and adverse events.
Compilation of management guidelines for methotrexate-related toxicities.

Related Experiment Videos

Last Updated: May 31, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Main Results:

Methotrexate exerts its therapeutic effects through complex immunomodulatory pathways.
Common toxicities include gastrointestinal issues, hepatotoxicity, and myelosuppression.
Proactive monitoring and specific interventions can mitigate most adverse effects.

Conclusions:

Methotrexate remains a cornerstone therapy for moderate to severe psoriasis and psoriatic arthritis.
A thorough understanding of its mechanism and toxicity profile is essential for safe and effective clinical application.
Effective management strategies are available to address potential adverse events, ensuring patient safety and treatment adherence.